| 發表論文 | - Prognostic value of interim CT-based peritumoral and intratumoral radiomics in laryngeal and hypopharyngeal cancer patients undergoing definitive radiotherapy.
Radiother Oncol 2023, 189:109938. (SCI, IF = 5.7)
- Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study. Radiother Oncol 2021, 154:76-86. (SCI, IF = 5.7)
- Efficacy of Postoperative Unilateral Neck Irradiation in Patients with Buccal Mucosa Squamous Carcinoma with Extranodal Extension: A Propensity Score Analysis. Cancers (Basel) 2021, 13. (SCI, IF = 5.2)
- Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy. Cancers (Basel) 2020, 12. (SCI, IF = 5.2)
- A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma. Cancer Med 2020, 9:2134-45. (SCI, IF = 4.0)
- Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma. J Cancer 2019, 10:3958-66. (SCI, IF = 3.9)
- Human Costars Family Protein ABRACL Modulates Actin Dynamics and Cell Migration and Associates with Tumorigenic Growth. International journal of molecular sciences 2021, 22. (SCI, IF = 5.6)
- Long-term outcomes of frontline intensification in primary CNS lymphoma: A real-world single-center experience. Cancer Med 2023, 12:8089-101. (SCI, IF = 4.0)
- Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy. Cancer Med 2021, 10:649-58. (SCI, IF = 4.0)
- Oncological Outcomes After Hippocampus-Sparing Whole-Brain Radiotherapy in Cancer Patients With Newly Diagnosed Brain Oligometastases: A Single-Arm Prospective Observational Cohort Study in Taiwan. Frontiers in oncology 2021, 11:784635. (SCI, IF = 4.7)
- Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era. Biomedicines 2022, 10. (SCI, IF = 4.7)
|
